AMRN Amarin Corp

RNS Number:5382A
Amarin Corporation Plc
19 July 2007


                                     
                              AMARIN CONCLUDES AGM

                             AMARIN CORPORATION PLC

LONDON, United Kingdom, July 19, 2007 Amarin Corporation plc today held its
annual general meeting in London. All twelve resolutions proposed to the meeting
were passed by the shareholders.


Contacts:


Amarin:                                   +44 (0) 207 907 2442

Rick Stewart                              Chief Executive Officer

Alan Cooke                                Chief Financial Officer

investor.relations@amarincorp.com


Investors:

Lippert/Heilshorn & Associates, Inc.

Anne Marie Fields                         +1 212 838 3777

Bruce Voss                                +1 310 691 7100


Media:

Powerscourt                               +44 (0) 207 250 1446

Paul Durman

Sarah Daly


Davy:

Ivan Murphy                               +353 (0) 1 6796363

Fergal Meegan



About Amarin


Amarin is committed to improving the lives of patients suffering from diseases
of the central nervous system. Our goal is to be a leader in the research,
development and commercialization of novel drugs that address unmet patient
needs.

Amarin's core development pipeline includes, in addition to Miraxion for several
therapeutic indications, four other key development programs in Parkinson's
disease, epilepsy seizures, memory and cognition and our proprietary
pre-clinical combinatorial lipid program.

Amarin has its primary stock market listing in the US on the Nasdaq Capital
Market ("AMRN") and secondary listings in the UK and Ireland on AIM ("AMRN") and
IEX ("H2E") respectively.

For press releases and other corporate information, visit the Amarin website at
http://www.amarincorp.com. 

Information on our website does not form part of this press release.

Ends.

                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMUKAORBSRBAAR

Amarin (LSE:AMRN)
Historical Stock Chart
From Jun 2024 to Jul 2024

Amarin (LSE:AMRN)
Historical Stock Chart
From Jul 2023 to Jul 2024